Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

Study shows high-dose vaccines work better for older adults while cell-based versions benefit younger people as respiratory ...

The vaccine has been approved by HSA for use in individuals aged 2 to 49 years. Read more at straitstimes.com. Read more at ...

Officials say it's one of many lessons learned from unusual flu season. April 1, 2010— -- With the first season of H1N1 swine flu vaccinations winding down, government officials are encouraging ...

GENEVA — As swine flu cases topped 6,600 worldwide, vaccine makers and other experts met Thursday at the World Health Organization to discuss the tough decisions that must be made quickly to fight the ...

One shot of 2009 H1N1 vaccine, instead of two, may generate a sufficient antibody response against the virus in children ages six months to nine years, researchers report. Under current government ...

Public health officials have been warning for some time that nothing about the flu is predictable. But here’s something that is: When it comes to a new strain of the flu like H1N1, which has already ...

A new H3N2 flu variant, subclade K, is spreading in the US, with concerns about its resistance to this year's flu vaccine and ...

WASHINGTON (Reuters) - It is too soon to determine whether tens of thousands of doses of H1N1 swine flu vaccine may have to be thrown out if they are not used before their expiration date, a U.S.